Monday, September 25, 2023
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
Daily Remedy
  • Home
  • Articles
  • Podcasts
    A conversation with Miss VJ Gray, a chronic pain patient and advocate

    A conversation with Miss VJ Gray, a chronic pain patient and advocate

    July 13, 2023
    A conversation with Kim, a chronic pain patient

    A conversation with Kim, a chronic pain patient

    July 13, 2023
    A conversation with Milissa Wojta Weiss, chronic pain patient

    A conversation with Milissa, chronic pain patient

    June 26, 2023
    A conversation with Mr. Bill Murphy, chronic pain patient advocate

    A conversation with Mr. Bill Murphy, chronic pain patient advocate

    June 19, 2023
    A conversation with Mr. Tom Hayashi, chronic pain patient advocate

    A conversation with Mr. Tom Hayashi, chronic pain patient advocate

    June 19, 2023
    A conversation with Dr. Felix Brizuela

    A conversation with Dr. Felix Brizuela

    June 19, 2023
  • Surveys

    Surveys

    Patients and patient advocates, it's time to tell your story!

    Patients and patient advocates, it’s time to tell your story!

    by Jay K Joshi
    April 9, 2023
    Does inflation affect your spending

    Does inflation affect how you use your deductible?

    by Jay K Joshi
    March 8, 2023

    Survey Resutls

    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    October 16, 2022
  • About Us
  • Contact us
  • Support Us
  • Shop DME
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    A conversation with Miss VJ Gray, a chronic pain patient and advocate

    A conversation with Miss VJ Gray, a chronic pain patient and advocate

    July 13, 2023
    A conversation with Kim, a chronic pain patient

    A conversation with Kim, a chronic pain patient

    July 13, 2023
    A conversation with Milissa Wojta Weiss, chronic pain patient

    A conversation with Milissa, chronic pain patient

    June 26, 2023
    A conversation with Mr. Bill Murphy, chronic pain patient advocate

    A conversation with Mr. Bill Murphy, chronic pain patient advocate

    June 19, 2023
    A conversation with Mr. Tom Hayashi, chronic pain patient advocate

    A conversation with Mr. Tom Hayashi, chronic pain patient advocate

    June 19, 2023
    A conversation with Dr. Felix Brizuela

    A conversation with Dr. Felix Brizuela

    June 19, 2023
  • Surveys

    Surveys

    Patients and patient advocates, it's time to tell your story!

    Patients and patient advocates, it’s time to tell your story!

    by Jay K Joshi
    April 9, 2023
    Does inflation affect your spending

    Does inflation affect how you use your deductible?

    by Jay K Joshi
    March 8, 2023

    Survey Resutls

    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    October 16, 2022
  • About Us
  • Contact us
  • Support Us
  • Shop DME
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Financial Markets

End of Year Healthcare IPO Bubble

Jay K Joshi by Jay K Joshi
September 27, 2021
in Financial Markets
0

Every end is the beginning of something new.

As we approach the last quarter (Q4) of 2021, we begin to see more healthcare startups and pending unicorns raise funds at ever higher valuations.

Devoted Health, an insurer that offers personal guidance and healthcare services to patients, is reportedly raising around $1.2 billion at an $11.5 billion valuation. The company has around 40,000 members, which equates to a valuation of $287,000 per member.

To put that into context, last year, Clover Health, another hybrid provider-insurer, became a unicorn at a valuation of $65,000 per member. Brand New Day, another competitor in the space, was acquired last year at $14,600 per member when it had 43,000 members.

Besides the intriguing names of these successful healthcare startups is an equally intriguing rise in valuations. Normally, the success of one startup paves a path for competitor startups and leads to a rise in valuations for all companies within the market. But the rise is not this dramatic.

And whenever we see dramatic rises in valuations, we often think of market bubbles, the inevitable market downturn that takes company valuations with it. Already we see signs of previously highly-valued healthcare startups struggling in the public market.

Oscar Health, a hybrid provider-insurer, lost 45% of its value since going public. The aforementioned Clover Health lost 25% of its value on the public market. Yet the market continues to support higher valuations of healthcare startups.

Inflated valuations that defy market logic and accelerating valuations for pre-IPO startups all point to an inevitable bursting of the healthcare market bubble.

But in our increasingly startup happy healthcare economy, it seems less likely we will see a systemic market downturn, and more likely we will see individual catastrophic flame outs.

Companies with little to no sustainable business model or competitive advantage that manage to raise astronomical sums at implausible valuations. These are the companies to look out for.

They are distinguished by two things – whimsical branding efforts and regulatory risks.

One such potential flame out, Accolade Health, is now entering the virtual primary care market, branding its new service line as personalized healthcare. But there is little to distinguish its virtual healthcare service offerings from other models of telemedicine. It is simply a branding exercise that fails to hold to scrutiny once you get around the catchphrases.

Contrast this marketing gimmick with Oak Street Health, a leading provider of traditional primary care services. Oak Street Health recently inked a deal to be the exclusive provider of AARP Medicare plans. Such deals create a competitive advantage for Oak Street Health by blocking competitors from entering the primary care space.

Companies that fail to achieve similar competitive advantages and rely on marketing slogans will be exposed in the public market. The same goes for companies that succeed on the edges of regulatory risk, including companies that inflate profits through inflated risk assessments of patients.

Recently the Office of Inspector General (OIG) released a report criticizing healthcare service companies for excessively milking Medicare dollars by overinflating the risk in managing their patients. The OIG was particularly critical of United Healthcare, exposing the company’s outsized profits garnered through chart reviews alone.

The bottom line is the fundamentals hold true. Healthcare has fallen in love with startup culture and valuations are rising as a result of that relationship. But the IPO market remains brutal as ever. They will not hesitate to lower the valuation for any company that does not meet its projected earnings.

That come from sustainable business models and defined competitive advantages. Companies that lack either will rely on rebranding existing clinical services as novel or teetering on the edges of regulatory risk.

These are the flame outs, the ones that will implode in the IPO market. To predict who they are, just look at how they market their services and how the government enforces the regulations.

Those tells are the beginning of the end.

ShareTweet
Jay K Joshi

Jay K Joshi

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

YouTube Video VVUxUDVQenU5RTFjUVFKNDY2ZlBmdFB3LkFyVnNsSEpZeTBF We speak with Kim, who shares her story of medical neglect and patient abandonment.

#burdenofpain
Load More... Subscribe

Expert vs. Lay Testimony

Visuals

NADAC (National Average Drug Acquisition Cost)

NADAC (National Average Drug Acquisition Cost)

by Jay K Joshi
January 29, 2023
0

We list the acquisition price of drugs that are covered under the Medicaid Drug Rebate Program - effectively, how much does the government pay for common drugs utilized by patients on Medicaid. Drugs listed are from A-CH.  

Read more

Twitter Updates

Tweets by DailyRemedy1

Newsletter

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do

Popular

  • War Elephants of Healthcare

    War Elephants of Healthcare

    0 shares
    Share 0 Tweet 0
  • The Curious Case of Dr. Xiulu Ruan

    1 shares
    Share 0 Tweet 0
  • Malicious Prosecution and Fabrication of Evidence

    0 shares
    Share 0 Tweet 0
  • My Long-Term Relationships with Migraine and Literature

    0 shares
    Share 0 Tweet 0
  • Open Letter to Chief Judge Jon E. DeGuilio

    0 shares
    Share 0 Tweet 0
  • 624 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Newsletter

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2023 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • About Us
  • Contact us
  • Support Us
  • Shop DME

© 2023 Daily Remedy

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do